These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16045810)

  • 1. Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS).
    Moscrip TD; Terrace HS; Sackeim HA; Lisanby SH
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):1-11. PubMed ID: 16045810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A primate model of anterograde and retrograde amnesia produced by convulsive treatment.
    Moscrip TD; Terrace HS; Sackeim HA; Lisanby SH
    J ECT; 2004 Mar; 20(1):26-36. PubMed ID: 15087994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function.
    Spellman T; McClintock SM; Terrace H; Luber B; Husain MM; Lisanby SH
    Biol Psychiatry; 2008 Jun; 63(12):1163-70. PubMed ID: 18262171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy.
    Lisanby SH; Luber B; Schlaepfer TE; Sackeim HA
    Neuropsychopharmacology; 2003 Oct; 28(10):1852-65. PubMed ID: 12865903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurophysiological characterization of high-dose magnetic seizure therapy: comparisons with electroconvulsive shock and cognitive outcomes.
    Cycowicz YM; Luber B; Spellman T; Lisanby SH
    J ECT; 2009 Sep; 25(3):157-64. PubMed ID: 19300292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Seizure Expression Between Magnetic Seizure Therapy and Electroconvulsive Shock.
    Cycowicz YM; Rowny SB; Luber B; Lisanby SH
    J ECT; 2018 Jun; 34(2):95-103. PubMed ID: 29240021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential neurophysiological effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS) in non-human primates.
    Cycowicz YM; Luber B; Spellman T; Lisanby SH
    Clin EEG Neurosci; 2008 Jul; 39(3):144-9. PubMed ID: 18751564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of magnetic seizure therapy on anterograde and retrograde amnesia in treatment-resistant depression.
    Kayser S; Bewernick BH; Wagner S; Schlaepfer TE
    Depress Anxiety; 2020 Feb; 37(2):125-133. PubMed ID: 31682325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial memory impairment in Morris water maze after electroconvulsive seizures.
    Svensson M; Hallin T; Broms J; Ekstrand J; Tingström A
    Acta Neuropsychiatr; 2017 Feb; 29(1):17-26. PubMed ID: 27139778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of electroconvulsive therapy and magnetic seizure therapy on acute memory retrieval.
    Polster JD; Kayser S; Bewernick BH; Hurlemann R; Schlaepfer TE
    J ECT; 2015 Mar; 31(1):13-9. PubMed ID: 24853650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylephrine and ECS-induced retrograde amnesia.
    Anand A; Andrade C; Sudha S; Guido S; Venkataraman BV
    J ECT; 2001 Sep; 17(3):166-9. PubMed ID: 11528305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential heart rate response to magnetic seizure therapy (MST) relative to electroconvulsive therapy: a nonhuman primate model.
    Rowny SB; Cycowicz YM; McClintock SM; Truesdale MD; Luber B; Lisanby SH
    Neuroimage; 2009 Sep; 47(3):1086-91. PubMed ID: 19497373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Baseline Cognitive Function in the Neurocognitive Effects of Electroconvulsive Therapy in Depressed Elderly Patients.
    Dybedal GS; Tanum L; Sundet K; Bjølseth TM
    Clin Neuropsychol; 2015; 29(4):487-508. PubMed ID: 26029851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dissociation between anterograde and retrograde amnesia after treatment with electroconvulsive therapy: a naturalistic investigation.
    O'Connor M; Lebowitz BK; Ly J; Panizzon MS; Elkin-Frankston S; Dey S; Bloomingdale K; Thall M; Pearlman C
    J ECT; 2008 Jun; 24(2):146-51. PubMed ID: 18580560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal pharmacotherapy for the attenuation of electroconvulsive shock-induced anterograde and retrograde amnestic deficits.
    Faruqi S; Andrade C; Ramteke S; Joseph J; Venkataraman BV; Naga Rani MA
    Convuls Ther; 1995 Dec; 11(4):241-7. PubMed ID: 8919574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone in the prevention of the adverse cognitive effects of ECT: a within-subject, placebo controlled study.
    Prudic J; Fitzsimons L; Nobler MS; Sackeim HA
    Neuropsychopharmacology; 1999 Aug; 21(2):285-93. PubMed ID: 10432476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia.
    Nagaraja N; Andrade C; Sudha S; Madan Singh N; Chandra JS; Venkataraman BV
    Psychopharmacology (Berl); 2007 Jan; 190(1):73-80. PubMed ID: 17072590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of the comparative efficacy of 100 Hz magnetic seizure therapy and electroconvulsive therapy in persistent depression.
    Fitzgerald PB; Hoy KE; Elliot D; McQueen S; Wambeek LE; Chen L; Clinton AM; Downey G; Daskalakis ZJ
    Depress Anxiety; 2018 May; 35(5):393-401. PubMed ID: 29329499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of component processes of spatial working memory by electroconvulsive shock but not magnetic seizure therapy.
    McClintock SM; DeWind NK; Husain MM; Rowny SB; Spellman TJ; Terrace H; Lisanby SH
    Int J Neuropsychopharmacol; 2013 Feb; 16(1):177-87. PubMed ID: 22217479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable seizure characteristics in magnetic seizure therapy and electroconvulsive therapy for major depression.
    Kayser S; Bewernick BH; Hurlemann R; Soehle M; Schlaepfer TE
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1541-50. PubMed ID: 23820052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.